Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06195865 | Autologous vs. Implant-based Breast Reconstruction(GoBreast II) | recruiting | N/A | 250 | Vastra Gotaland RegionOTHER_GOV | 1 | Jul 3, 2025 | clinicaltrials |
| NCT06402435 | SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer | recruiting | Phase 2 | 50 | Hubei Cancer HospitalOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT06995118 |
| The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction(HUAXI-h-01) |
| recruiting |
| N/A |
| 337 |
| Du ZhengguiOTHER |
| 1 |
| Jul 2, 2025 |
| clinicaltrials |
| NCT07047495 | Personalization of External Beam Radiation Therapy in Localised Tumours(MINIONS) | recruiting | — | 35 | European Institute of OncologyOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT05896865 | Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer(RADAPT-N3) | recruiting | N/A | 120 | Samsung Medical CenterOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT05907681 | Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M) | recruiting | — | 400 | Samsung Medical CenterOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT05933733 | Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer(SALT-LRR) | recruiting | — | 190 | Samsung Medical CenterOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT06421285 | Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients | recruiting | N/A | 60 | Asan Medical CenterOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT05796973 | Measuring Oncological Value of Exercise and Statin(MOVES) | recruiting | Phase 3 | 240 | Tampere University HospitalOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT06308029 | Effectiveness of an eHealth Self-management Support Program for Persistent Pain After Breast Cancer Treatment(PECAN) | recruiting | N/A | 270 | Universiteit AntwerpenOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT06500208 | Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC | recruiting | Phase 2 | 48 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT06839001 | CRYoablation for Small Tumors As Local Treatment - SIX Trial(CRYSTAL - SIX) | recruiting | Phase 3 | 750 | Hospital do CoracaoOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT06665178 | Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast Cancer | recruiting | Phase 2 | 20 | British Columbia Cancer AgencyOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT07003074 | A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer | recruiting | Phase 3 | 642 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06769425 | HS-10502 Combination Treatment in Patients With Advanced Solid Tumors(HS-10502) | recruiting | Phase 1 | 157 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 24, 2025 | clinicaltrials |
| NCT07033507 | Diffusion Coefficient and Micro-calcifications to Kaiser Score in Evaluation of BI-RADS 4 Breast Lesions | recruiting | — | 80 | Mansoura University HospitalOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT07030569 | RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study(RADIOSPHER2) | recruiting | — | 500 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT06383767 | A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer | recruiting | Phase 3 | 378 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 19, 2025 | clinicaltrials |
| NCT06568692 | A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer | recruiting | Phase 2 | 90 | Processa PharmaceuticalsINDUSTRY | 1 | Jun 19, 2025 | clinicaltrials |
| NCT07021846 | Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer(DEBoRa) | recruiting | N/A | 132 | Fondazione Policlinico Universitario Campus Bio-MedicoOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT07021911 | Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer(COMBaRT) | recruiting | — | 300 | Fondazione Policlinico Universitario Campus Bio-MedicoOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT06150898 | Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)(KePreSt) | recruiting | Phase 2 | 112 | Jules Bordet InstituteOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT07019233 | A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel | recruiting | N/A | 118 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT07014410 | Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer | recruiting | Phase 2 | 63 | Zhejiang Cancer HospitalOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT07012720 | Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer | recruiting | N/A | 71 | Xijing HospitalOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT06515470 | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer | recruiting | Phase 1 | 82 | Biotheryx, Inc.INDUSTRY | 1 | Jun 6, 2025 | clinicaltrials |
| NCT06596915 | Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 167 | Shandong Boan Biotechnology Co., LtdINDUSTRY | 1 | Jun 6, 2025 | clinicaltrials |
| NCT06678048 | Arsenous Acid for Refractory Triple-Negative Breast Cancer | recruiting | Phase 2 | 12 | Sun Yat-sen UniversityOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT06993714 | 3D-printed Biodegradable Breast Implants for Breast Restoration | recruiting | Phase 2 | 120 | Xijing HospitalOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT07008339 | Impact of Nipple Reconstruction in Mastectomized Patients Using Cross-Linked Hyaluronic Acid Injection.(RECHIAL) | recruiting | N/A | 138 | Germans Trias i Pujol HospitalOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT05740956 | A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 318 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 5, 2025 | clinicaltrials |
| NCT06337214 | TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy | recruiting | N/A | 80 | Taipei City HospitalOTHER_GOV | 1 | Jun 4, 2025 | clinicaltrials |
| NCT07003009 | Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer | recruiting | N/A | 30 | Istanbul Training and Research HospitalOTHER_GOV | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06672120 | Exercise in Triple- Negative Breast Cancer(ExACT-ICI) | recruiting | N/A | 120 | Technical University of MunichOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT05838066 | Efficacy and Safety of KN026 in Combination With HB1801 in the First-line Treatment of Subjects With HER2-positive Recurrent or Metastatic Breast Cancer. | recruiting | Phase 3 | 880 | Shanghai JMT-Bio Inc.INDUSTRY | 1 | May 30, 2025 | clinicaltrials |
| NCT06677879 | A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer. | recruiting | Phase 2 | 780 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT01793168 | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford(CoRDS) | recruiting | — | 20,000 | Sanford HealthOTHER | 2 | May 29, 2025 | clinicaltrials |
| NCT04824027 | Breast Elasticity Imaging During Neoadjuvant Chemotherapy | recruiting | N/A | 50 | Columbia UniversityOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT06049355 | EMBRACE: Exercising Together | recruiting | Phase 2 | 400 | OHSU Knight Cancer InstituteOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT06991790 | Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration | recruiting | — | 51 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT06991946 | Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain(HOPE-Focus) | recruiting | — | 300 | SOLTI Breast Cancer Research GroupOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT06992336 | Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy | recruiting | Phase 2 | 411 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT06989450 | Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer | recruiting | N/A | 140 | Sidekick HealthINDUSTRY | 1 | May 25, 2025 | clinicaltrials |
| NCT05333328 | OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk(INTERSTELLAR) | recruiting | Phase 4 | 418 | Gangnam Severance HospitalOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06955702 | Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer Patients | recruiting | N/A | 120 | University of SalamancaOTHER | 1 | May 22, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Jul 3, 2025source: clinicaltrials